These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 38127682)
1. Prospective Study of the Multisite Spread of a Medication Safety Intervention: Factors Common to Hospitals With Improved Outcomes. Kaplan HC; Goldstein SL; Rubinson C; Daraiseh N; Zhang F; Rodgers IM; Dahale DS; Askenazi DJ; Somers MJG; Zaritsky JJ; Misurac J; Chadha V; Yonekawa KE; Sutherland SM; Weng PL; Walsh KE Am J Med Qual; 2024 Jan-Feb 01; 39(1):21-32. PubMed ID: 38127682 [TBL] [Abstract][Full Text] [Related]
2. Use of the NINJA (Nephrotoxic Injury Negated by Just-in-Time Action) Program to Identify Nephrotoxicity in Pediatric Patients with Cystic Fibrosis. Newton ES; Kurzen EA; Linnemann RW; Shin HS J Pediatr Pharmacol Ther; 2021; 26(4):379-383. PubMed ID: 34035683 [TBL] [Abstract][Full Text] [Related]
14. The role of the clinical pharmacist in the prevention of drug-induced acute kidney injury in the intensive care unit. Polat EC; Koc A; Demirkan K J Clin Pharm Ther; 2022 Dec; 47(12):2287-2294. PubMed ID: 36394173 [TBL] [Abstract][Full Text] [Related]
15. Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. Menon S; Kirkendall ES; Nguyen H; Goldstein SL J Pediatr; 2014 Sep; 165(3):522-7.e2. PubMed ID: 24928698 [TBL] [Abstract][Full Text] [Related]
16. A qualitative dual-site analysis of the pharmacist discharge care (PHARM-DC) intervention using the CFIR framework. Murry LT; Keller MS; Pevnick JM; Schnipper JL; Kennelty KA; BMC Health Serv Res; 2022 Feb; 22(1):186. PubMed ID: 35151310 [TBL] [Abstract][Full Text] [Related]
17. Outcomes of a pharmacist-driven vancomycin monitoring initiative in a community hospital. Joseph K; Ramireddy K; Madison G; Turco T; Lui M J Clin Pharm Ther; 2021 Aug; 46(4):1103-1108. PubMed ID: 33768555 [TBL] [Abstract][Full Text] [Related]
18. Decreases in Nephrotoxic Pain Medications Are Not Associated With Increased Opioid Utilization in Critically Ill Children. Stenson EK; DeMasellis G; Shah A; Reiter PD; Brinton J; Martin S; Iwanowski M; Rannie M; Soranno DE; Gist KM Pediatr Crit Care Med; 2022 Dec; 23(12):e564-e573. PubMed ID: 36066647 [TBL] [Abstract][Full Text] [Related]
19. Use of urine neutrophil gelatinase-associated lipocalin for nephrotoxic medication acute kidney injury screening in neonates. Slagle CL; Hemmelgarn T; Gavigan HW; Krallman KA; Goldstein SL J Perinatol; 2024 Mar; ():. PubMed ID: 38514742 [TBL] [Abstract][Full Text] [Related]
20. Impact of early in-hospital medication review by clinical pharmacists on health services utilization. Hohl CM; Partovi N; Ghement I; Wickham ME; McGrail K; Reddekopp LN; Sobolev B PLoS One; 2017; 12(2):e0170495. PubMed ID: 28192477 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]